Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA

J Immunol. 2017 Jul 15;199(2):391-396. doi: 10.4049/jimmunol.1601882. Epub 2017 Jun 12.

Abstract

Production of active TGF-β is regulated at a posttranslational level and implies release of the mature cytokine dimer from the inactive, latent TGF-β precursor. There are several cell-type specific mechanisms of TGF-β activation. We identified a new mechanism operating on the surface of human regulatory T cells and involving membrane protein GARP, which binds latent TGF-β1. The paracrine activity of regulatory T cell-derived TGF-β1 contributes to immunosuppression and can be inhibited with anti-GARP Abs. Whether other immune cell types use surface GARP to activate latent TGF-β1 was not known. We show in this study that stimulated, human B lymphocytes produce active TGF-β1 from surface GARP/latent TGF-β1 complexes with isotype switching to IgA production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Cytokines / immunology
  • Humans
  • Immunoglobulin A / biosynthesis*
  • Immunoglobulin A / immunology
  • Immunoglobulin Class Switching*
  • Lymphocyte Activation
  • Membrane Proteins / metabolism*
  • Oligodeoxyribonucleotides / immunology
  • Protein Binding
  • Recombination, Genetic
  • T-Lymphocytes, Regulatory / immunology
  • Transforming Growth Factor beta1 / immunology
  • Transforming Growth Factor beta1 / metabolism*

Substances

  • CPG-oligonucleotide
  • Cytokines
  • Immunoglobulin A
  • LRRC32 protein, human
  • Membrane Proteins
  • Oligodeoxyribonucleotides
  • Transforming Growth Factor beta1